{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:06Z","timestamp":1786119306685,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9,27]]},"DOI":"10.1097\/tp.0b013e3181b4aaf5","type":"journal-article","created":{"date-parts":[[2009,9,18]],"date-time":"2009-09-18T08:20:31Z","timestamp":1253262031000},"page":"799-802","source":"Crossref","is-referenced-by-count":8,"title":["Kidney After Nonrenal Transplantation\u2014The Impact of Alemtuzumab Induction"],"prefix":"10.1097","volume":"88","author":[{"given":"Ron","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henkie P.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Blisard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmjeet S.","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Dvorchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"McCauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrius","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Wallis","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Webber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Kurland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"McCurry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Abu-Elmagd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Starzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210211","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ.","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"issue":"suppl","key":"R2-10-20210211","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1385\/MO:19:2S:S03","article-title":"A personal history of the CAMPATH-1H antibody.","volume":"19","author":"Waldmann","year":"2002","journal-title":"Med Oncol"},{"key":"R3-10-20210211","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0140-6736(05)77739-4","article-title":"Prope tolerance, perioperative Campath 1H, and low- dose cyclosporine monotherapy in renal allograft recipients.","volume":"351","author":"Calne","year":"1998","journal-title":"Lancet"},{"issue":"suppl","key":"R4-10-20210211","first-page":"397","article-title":"Alemtuzumab facilitates prednisone free immunosuppression in kidney transplant recipients with no early rejection.","volume":"2","author":"Stuart","year":"2002","journal-title":"Am J Transplant"},{"key":"R5-10-20210211","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-6143.2003.00120.x","article-title":"Campath-1H induction plus rapamycin monotherapy for renal transplantation results of a pilot study.","volume":"3","author":"Knechtle","year":"2003","journal-title":"Am J Transplant"},{"key":"R6-10-20210211","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.TP.0000071362.99021.D9","article-title":"Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).","volume":"76","author":"Kirk","year":"2003","journal-title":"Transplantation"},{"key":"R7-10-20210211","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jamcollsurg.2004.12.024","article-title":"Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or Campath.","volume":"200","author":"Shapiro","year":"2005","journal-title":"J Am Coll Surg"},{"key":"R8-10-20210211","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jpeds.2006.01.008","article-title":"Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.","volume":"148","author":"Shapiro","year":"2006","journal-title":"J Pediatr"},{"key":"R9-10-20210211","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/j.1600-6143.2006.01495.x","article-title":"Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.","volume":"6","author":"Tan","year":"2006","journal-title":"Am J Transpl"},{"key":"R10-10-20210211","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0b013e31816a8a6d","article-title":"Alemtuzumab preconditioning with tacrolimus monotherapy\u2014The impact of serial monitoring for donor-specific antibody.","volume":"85","author":"Shapiro","year":"2008","journal-title":"Transplantation"},{"key":"R12-10-20210211","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/lt.20536","article-title":"Immunosuppression for liver transplantation in HCV-infected patients: Mechanism-based principles.","volume":"11","author":"Eghtesad","year":"2005","journal-title":"Liver Transpl"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200909270-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:20Z","timestamp":1786039160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200909270-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,27]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181b4aaf5","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9,27]]}}}